Form 3 - Initial statement of beneficial ownership of securities

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Form 3 - Initial statement of beneficial ownership of securities

NovoCure (NASDAQ:NVCR)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more NovoCure Charts.

NovoCure (NASDAQ:NVCR)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more NovoCure Charts.

NovoCure Ltd News

Form 3 - Initial statement of beneficial ownership of securities
Monday 6 January 2025 (1 day ago) • Edgar (US Regulatory)

Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference
Friday 3 January 2025 (5 days ago) • Business Wire

Novocure gibt positive Ergebnisse der Phase-3-Studie PANOVA-3 zur Tumor Treating Fields (TTFields)-Therapie bei Bauchspeicheldrüsenkrebs bekannt
Thursday 5 December 2024 (1 month ago) • Business Wire

ノボキュア、膵がんに対する腫瘍治療電場療法（TTフィールド）の第3相臨床試験PANOVA-3のトップライン結果を発表
Wednesday 4 December 2024 (1 month ago) • Business Wire

Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer
Monday 2 December 2024 (1 month ago) • Business Wire

Form 8-K - Current report
Monday 2 December 2024 (1 month ago) • Edgar (US Regulatory)

Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer
Monday 2 December 2024 (1 month ago) • Business Wire

Novocure to Participate in Upcoming Investor Conferences
Wednesday 27 November 2024 (1 month ago) • Business Wire

Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
Thursday 21 November 2024 (2 months ago) • Business Wire

FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
Thursday 21 November 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 4 November 2024 (2 months ago) • Edgar (US Regulatory)

More NovoCure Ltd News Articles

Asia Broadband (PK)

Kraig Biocraft Laborator... (QB)

Accredited Solutions (PK)

Apple Rush (PK)

Decentral Life (PK)

Good Vibrations Shoes (PK)

GBT Technologies (PK)

Rennova Health (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions